TAR-200 achieved an 82% tumor elimination rate in high-risk non-muscle-invasive bladder cancer patients resistant to previous treatments. The device releases gemcitabine into the bladder over three ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback